Sg3 Management, LLC Immatics N.V. Transaction History
Sg3 Management, LLC
- $0
- Q3 2023
A detailed history of Sg3 Management, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Sg3 Management, LLC holds 28,100 shares of IMTX stock, worth $140,500. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,100Holding current value
$140,500% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding IMTX
# of Institutions
92Shares Held
82.1MCall Options Held
313KPut Options Held
377K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.6MShares$53 Million0.05% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$46.9 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$36.4 Million0.57% of portfolio
-
Rtw Investments, LP New York, NY6.54MShares$32.7 Million0.76% of portfolio
-
Vestal Point Capital, LP New York, NY6.28MShares$31.4 Million2.65% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $381M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...